Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

China · Delayed Price · Currency is CNY

13.39

+0.05 (0.37%)

Aug 20, 2026, 3:04 PM CST

-24.56% (1Y)

Market Cap	11.04B -24.6%
Revenue (ttm)	2.68B -7.8%
Net Income	204.33M +41.7%
EPS	0.25 +41.6%
Shares Out	824.60M
PE Ratio	54.07
Forward PE	33.90
Dividend	0.08 (0.62%)
Ex-Dividend Date	Apr 29, 2026

Volume	13,121,900
Open	13.29
Previous Close	13.34
Day's Range	13.29 - 13.66
52-Week Range	12.05 - 18.26
Beta	-0.12
Analysts	Buy
Price Target	18.00 (+34.43%)
Earnings Date	Aug 22, 2026

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti-tumor, urology, orthopedics, and anti-infection applications. It also provides active pharmaceutical ingredients, including heparin, chondroitin sulfa... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1998

Employees 2,583

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002675

Full Company Profile

Financial Performance

In 2025, SHE:002675's revenue was 2.74 billion, a decrease of -4.46% compared to the previous year's 2.87 billion. Earnings were 195.63 million, an increase of 6.42%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 002675 stock is "Buy." The 12-month stock price target is ¥18.00, which is an increase of 34.43% from the latest price.

Price Target

¥18.00

(34.43% upside)

Analyst Consensus: Buy

Stock Forecasts